Your browser doesn't support javascript.
loading
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.
Solomon, Andrew J; Arrambide, Georgina; Brownlee, Wallace J; Flanagan, Eoin P; Amato, Maria Pia; Amezcua, Lilyana; Banwell, Brenda L; Barkhof, Frederik; Corboy, John R; Correale, Jorge; Fujihara, Kazuo; Graves, Jennifer; Harnegie, Mary Pat; Hemmer, Bernhard; Lechner-Scott, Jeannette; Marrie, Ruth Ann; Newsome, Scott D; Rocca, Maria A; Royal, Walter; Waubant, Emmanuelle L; Yamout, Bassem; Cohen, Jeffrey A.
Afiliación
  • Solomon AJ; Department of Neurological Sciences, Larner College of Medicine at the University of Vermont, University Health Center, Burlington, VT, USA. Electronic address: andrew.solomon@uvm.edu.
  • Arrambide G; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Brownlee WJ; National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
  • Flanagan EP; Departments of Neurology and Laboratory Medicine and Pathology and the Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.
  • Amato MP; Department NEUROFARBA, University of Florence, Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
  • Amezcua L; Department of Neurology, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA.
  • Banwell BL; Department of Neurology, University of Pennsylvania, Division of Child Neurology, Philadelphia, PA, USA; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Barkhof F; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, UK.
  • Corboy JR; Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Correale J; Department of Neurology, Fleni Institute of Biological Chemistry and Physical Chemistry (IQUIFIB), Buenos Aires, Argentina; National Council for Scientific and Technical Research/University of Buenos Aires, Buenos Aires, Argentina.
  • Fujihara K; Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Koriyama, Japan; Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Koriyama, Japan.
  • Graves J; Department of Neurosciences, University of California, San Diego, CA, USA.
  • Harnegie MP; Cleveland Clinic Libraries, Cleveland Clinic, Cleveland, OH, USA.
  • Hemmer B; Department of Neurology, Klinikum rechts der Isar, Medical Faculty, Technische Universität München, Munich, Germany; Munich Cluster for Systems Neurology, Munich, Germany.
  • Lechner-Scott J; Department of Neurology, John Hunter Hospital, Newcastle, NSW Australia; Hunter Medical Research Institute Neurology, University of Newcastle, Newcastle, NSW, Australia.
  • Marrie RA; Departments of Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
  • Newsome SD; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Rocca MA; Neuroimaging Research Unit, Division of Neuroscience, Neurology Unit, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
  • Royal W; Department of Neurobiology and Neuroscience Institute, Morehouse School of Medicine, Atlanta, GA, USA.
  • Waubant EL; Weill Institute for Neuroscience, University of California, San Francisco, San Francisco, CA, USA.
  • Yamout B; Neurology Institute, Harley Street Medical Center, Abu Dhabi, United Arab Emirates.
  • Cohen JA; Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Lancet Neurol ; 22(8): 750-768, 2023 08.
Article en En | MEDLINE | ID: mdl-37479377
Accurate diagnosis of multiple sclerosis requires careful attention to its differential diagnosis-many disorders can mimic the clinical manifestations and paraclinical findings of this disease. A collaborative effort, organised by The International Advisory Committee on Clinical Trials in Multiple Sclerosis in 2008, provided diagnostic approaches to multiple sclerosis and identified clinical and paraclinical findings (so-called red flags) suggestive of alternative diagnoses. Since then, knowledge of disorders in the differential diagnosis of multiple sclerosis has expanded substantially. For example, CNS inflammatory disorders that present with syndromes overlapping with multiple sclerosis can increasingly be distinguished from multiple sclerosis with the aid of specific clinical, MRI, and laboratory findings; studies of people misdiagnosed with multiple sclerosis have also provided insights into clinical presentations for which extra caution is warranted. Considering these data, an update to the recommended diagnostic approaches to common clinical presentations and key clinical and paraclinical red flags is warranted to inform the contemporary clinical evaluation of patients with suspected multiple sclerosis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Neurol Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article
...